AU Stock MarketDetailed Quotes

PER Percheron Therapeutics Ltd

Watchlist
  • 0.008
  • +0.001+14.29%
20min DelayTrading Dec 27 12:37 AET
8.70MMarket Cap-0.57P/E (Static)

Percheron Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Percheron Therapeutics Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/H11.200M / 0.000--

Percheron Therapeutics Ltd Earnings Reports

  • Percheron Therapeutics Ltd: Percheron Receives $2.35 million R&D Tax Incentive Rebate

    Oct 7 18:37 ET

  • Percheron Therapeutics Ltd: Appendix 4E and Annual Report

    Aug 29 01:11 ET

  • Percheron Therapeutics Ltd: Half Yearly Report and Accounts

    Feb 28 01:20 ET

    • Analysis

    Analyst Rating

    Updated: Dec 18, 2024

    Hold

    • Strong Buy

      33.33%

    • Buy

      0.00%

    • Hold

      33.33%

    • Underperform

      0.00%

    • Sell

      33.33%

    Price Target

    No Data

    Heat List
    AU
    Overall
    Symbol
    Price
    % Chg

    No Data